[1
]Institute of Applied Biosciences, Centre for Research and Technology Hellas, Thessaloniki,
Greece;
[2
]Department of Molecular Medicine and Surgery, Karolinska Institute, Stockholm, Sweden;
[3
]Department of Molecular Biology and Genetics, Democritus University of Thrace, Alexandroupolis,
Greece;
[4
]International ImMunoGeneTics Information System (IMGT), Laboratoire d’ImmunoGénétique
Moléculaire (LIGM), Institut de Génétique Humaine (IGH), Unité Mixte de Recherche
(UMR), Centre National de la Recherche Scientifique (CNRS), Université de Montpellier,
Montpellier, France;
[5
]Department of Internal Medicine, Hematology and Oncology, Faculty of Medicine, Masaryk
University–University Hospital Brno, Brno, Czech Republic;
[6
]Center of Molecular Medicine, Central European Institute of Technology, Masaryk University,
Brno, Czech Republic;
[7
]Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom;
[8
]The Feinstein Institute for Medical Research, Northwell Health, Manhasset, NY;
[9
]MLL Munich Leukemia Laboratory, Munich, Germany;
[10
]University Hospital Medical Center, Ulm, Germany;
[11
]Deparment of Hematology, Rigshospitalet, Copenhagen University Hospital, Copenhagen,
Denmark;
[12
]Department of Immunology, Mayo Clinic, Rochester, MN;
[13
]Science for Life Laboratory, Department of Immunology, Genetics and Pathology, Uppsala
University, Uppsala, Sweden;
[14
]Strategic Research Program on CLL, B-Cell Neoplasia Unit, Division of Experimental
Oncology, Università Vita-Salute San Raffaele/Istituto di Ricovero e Cura a Carattere
Scientifico (IRCCS) Ospedale San Raffaele, Milan, Italy;
[15
]Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical
Center (UMC), Rotterdam, The Netherlands;
[16
]Assistance Publique–Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Department
of Biological Hematology, Sorbonne Université, UMR_S 1138, Centre de Recherche des
Cordeliers, Paris, France;
[17
]Department of Internal Medicine III, Ulm University, Ulm, Germany;
[18
]National Research Center for Hematology, Moscow, Russia;
[19
]Department of Experimental Medicine, University of Genoa, Genoa, Italy;
[20
]Centro de Investigacion Biomedica en Red en Oncologia (CIBERONC), Madrid, Spain;
[21
]Institut d’Investigacions Biomediques August Pi I Sunyer, Barcelona, Spain;
[22
]Molecular Pathology Unit, Haematology Department, Niguarda Cancer Center, Niguarda
Hospital, Milan, Italy;
[23
]Department of Laboratory Medicine, Medical University of Vienna, Vienna, Austria;
[24
]Faculty of Pharmacy, Ss Cyril and Methodius University of Skopje, Skopje, Republic
of Northern Macedonia;
[25
]Clinical Haematology, Belfast City Hospital, Belfast Health and Social Care Trust,
Belfast, United Kingdom;
[26
]Second Medical Department, University Hospital Schleswig-Holstein, Campus Kiel, Kiel,
Germany;
[27
]Hematology and Clinical Immunology Unit, Department of Medicine (DIMED), University
of Padua, Padua, Italy;
[28
]Veneto Institute of Molecular Medicine, Padua, Italy;
[29
]Division of Immunology, Transplantation and Infectious Diseases, IRCCS San Raffaele
Scientific Institute, Milan, Italy;
[30
]Division of Hematology, Department of Translational Medicine, University of Eastern
Piedmont–Ospedale Maggiore della Carità, Novara, Italy;
[31
]General Anatomopathology and Molecular Oncogenetics, Azienda Ospedaliero Universitaria
(AOU), City of Health and Science of Turin, Turin, Italy;
[32
]First Department of Propaedeutic Medicine, University of Athens, Athens, Greece;
[33
]Experimental Hematooncology Department, Medical University of Lublin, Lublin, Poland;
[34
]Institute of Molecular Genetics and Genetic Engineering, University of Belgrade, Belgrade,
Serbia;
[35
]MTA-SE Momentum Molecular Oncohematology Research Group, First Department of Pathology
and Experimental Cancer Research, Semmelweis University, Budapest, Hungary;
[36
]UO Molecular Pathology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy;
[37
]Department of Hematology, Amsterdam Infection and Immunity Institute, Cancer Center
Amsterdam, Amsterdam UMC–University of Amsterdam, Amsterdam, The Netherlands;
[38
]Department of Hematology, Faculty of Medicine, Ss Cyril and Methodius University of
Skopje, Skopje, Republic of Northern Macedonia;
[39
]Division of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland;
[40
]Department of Medicine, Faculty of Medicine, Kuwait University, Safat, Kuwait;
[41
]The Center for the Study of Haematological Malignancies, Nicosia, Cyprus;
[42
]Karaiskakio Foundation, Nicosia, Cyprus;
[43
]Laboratorio de Citogenètica Molecular, Laboratori de Citologia Hematològica, Servei
de Patologia i Servei de Hematologia, Hospital del Mar, Barcelona, Spain;
[44
]Clinic for Hematology, Clinical Center of Serbia, Belgrade, Serbia;
[45
]Hammersmith Hospital, London, United Kingdom;
[46
]Hematocrit (HCT) Unit, Hematology Department, G. Papanicolaou Hospital, Thessaloniki,
Greece;
[47
]Hospital Clinic of Barcelona, University of Barcelona, Barcelona, Spain;
[48
]University Hospital Cologne, Cologne, Germany;
[49
]Department I of Internal Medicine, University of Cologne, Cologne, Germany;
[50
]Department of Immunology, Mayo Clinic, Scottsdale, AZ;
[51
]Hematology Department, Nikea General Hospital, Pireaus, Greece; and
[52
]Clinical Genetics, Karolinska University Laboratory, Karolinska University Hospital,
Stockholm, Sweden
